Pregled bibliografske jedinice broj: 263942
Methylation status of PTCH promoter in tumors with alterations in Hh-Gli signaling pathway
Methylation status of PTCH promoter in tumors with alterations in Hh-Gli signaling pathway // Book of Abstracts of the HDBMB 2006 / Kovarik, Zrinka (ur.).
Zagreb, 2006. (predavanje, nije recenziran, sažetak, ostalo)
CROSBI ID: 263942 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Methylation status of PTCH promoter in tumors with alterations in Hh-Gli signaling pathway
Autori
Musani, Vesna ; Čretnik, Maja ; Orešković, Slavko ; Levanat, Sonja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
Book of Abstracts of the HDBMB 2006
/ Kovarik, Zrinka - Zagreb, 2006
Skup
Congress of the Croatian Society of Biochemistry and Molecular Biology on the occasion of the 30th anniversary
Mjesto i datum
Vodice, Hrvatska, 03.10.2006. - 07.10.2006
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Nije recenziran
Ključne riječi
methylation; patched promoter; ovarian tumors
Sažetak
PTCH, a known tumor suppressor has a central role in the HH-GLI signaling pathway. It is a 12-pass transmembrane glycoprotein, which inhibits Smo in the absence of Shh signal. If Shh is present, the repression of Smo is relieved and signaling can proceed down to Gli trancription factor and cause target gene transcription. It is known that epigenetic changes related to specific methylation patterns contribute to cancer development. Many tumor suppressor gene lose function if their promoter region is hypremethylaed, and such CpG sites often show increased mutation rate. Since functioning of the HH-GLI pathway is still not completely understood, we intend to examine DNA methylation of PTCH promoter. We used bisulfite genomic sequencing method (Frommer et al, PNAS, 1992) for the analysis of the methylation status of the PTCH promoter. The method is based on chemical alteration of DNA, where bisulfite reacts with DNA and, as a result, cytosine is deaminated into uracil, but 5-methylcytosine remains unaltered. Primers specefici for both methylated and unmethylated DNA were used to amplify a target sequence, which was then sequenced and analysed. PTCH promoter sequence was acquired from NCBI database (gi 14787441), and location of the Gli1 binding site and start codon were determined (Agren et al, Gene, 2004). The part of the sequence encompassing both these locations was screened for CpG islands. CpG island 1593 bp long, which includes 163 CpG sites, was determined and primers were designed to amplify both methylated and unmethylated DNA. Comparison of methylation patterns with previous expression analysis showed a significant correltion between PTCH promoter methylation and reduced PTCH expression.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb